Profound Medical to Participate in A.G.P.’s Virtual MedTech Summer Conference
July 22, 2021 16:30 ET
|
Profound Medical Corp.
TORONTO, July 22, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Release Second Quarter 2021 Financial Results on August 4 – Conference Call to Follow
July 15, 2021 16:30 ET
|
Profound Medical Corp.
TORONTO, July 15, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Participate in June Investor Conferences
May 25, 2021 16:30 ET
|
Profound Medical Corp.
TORONTO, May 25, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces Voting Results from the 2021 Annual Meeting of Shareholders and Management Changes
May 19, 2021 16:30 ET
|
Profound Medical Corp.
TORONTO, May 19, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce the voting results from its Annual Meeting of...
Profound Medical Announces First Quarter 2021 Financial Results
May 12, 2021 16:13 ET
|
Profound Medical Corp.
TORONTO, May 12, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical and Akumin Enter into U.S. Multi-Center Commercial Agreement for TULSA-PRO®
May 06, 2021 07:00 ET
|
Profound Medical Corp.
TORONTO, May 06, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Release First Quarter 2021 Financial Results on May 12 – Conference Call to Follow
April 21, 2021 16:30 ET
|
Profound Medical Corp.
TORONTO, April 21, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Participate in the 2021 Bloom Burton & Co. Virtual Healthcare Investor Conference
April 14, 2021 16:30 ET
|
Profound Medical Corp.
TORONTO, April 14, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces the Appointment of Cynthia Lavoie to its Board of Directors
March 03, 2021 07:00 ET
|
Profound Medical Corp.
TORONTO, March 03, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable,...
Profound Medical Announces Fourth Quarter and Full Year 2020 Financial Results
March 02, 2021 16:02 ET
|
Profound Medical Corp.
TORONTO, March 02, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...